Oh for sure, buying options comes with more risk.
But is clear communication too much to ask for?
These pre-clinical updates around Lupus and mRNA vaccine technology are lovely. But I want to know, is there still several years of pre-clinical work to be done? Or is this about to head into a clinical trial in the near term?
Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer, page-15
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $1.863K | 16.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103413 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 159073 | 5 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |